iCAD, Inc. Q1 2024 Earnings Call Transcript
ICAD Stock | USD 1.58 0.04 2.60% |
About 55% of Icad's shareholders are presently thinking to get in. The analysis of the overall investor sentiment regarding icad inc suggests that some traders are interested. The current market sentiment, together with Icad's historical and current headlines, can help investors time the market. In addition, many technical investors use icad inc stock news signals to limit their universe of possible portfolio assets.
Icad |
Operator Good day, ladies and gentlemen, and welcome to the iCAD Incorporated First Quarter 2024 Earnings Call.
Read at insidermonkey.com
Icad Fundamental Analysis
We analyze Icad's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Icad using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Icad based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Net Income
Net Income Comparative Analysis
Icad is currently under evaluation in net income category among its peers. Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
icad inc Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Icad stock to make a market-neutral strategy. Peer analysis of Icad could also be used in its relative valuation, which is a method of valuing Icad by comparing valuation metrics with similar companies.
Peers
Icad Related Equities
ESTA | Establishment Labs | 5.73 | ||||
CVRX | CVRx | 4.58 | ||||
MOVE | Movano | 4.36 | ||||
BMRA | Biomerica | 3.23 | ||||
AXGN | Axogen | 0.97 | ||||
SIBN | Si Bone | 0.72 | ||||
NVRO | Nevro Corp | 0.66 | ||||
SRDX | SurModics | 0.58 | ||||
LNSR | LENSAR | 0.27 | ||||
NVNO | EnVVeno Medical | 0.29 | ||||
PROF | Profound Medical | 0.40 | ||||
SGHT | Sight Sciences | 0.75 | ||||
FNA | Paragon 28 | 1.79 | ||||
SSKN | STRATA Skin | 3.61 | ||||
AIMD | Ainos | 4.26 |
Complementary Tools for Icad Stock analysis
When running Icad's price analysis, check to measure Icad's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Icad is operating at the current time. Most of Icad's value examination focuses on studying past and present price action to predict the probability of Icad's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Icad's price. Additionally, you may evaluate how the addition of Icad to your portfolios can decrease your overall portfolio volatility.
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
CEOs Directory Screen CEOs from public companies around the world | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |